Imigran Ftab

Sumatriptan, the active ingredient in Imigran Ftab, is a Triptan presented as an oral tablet for the acute treatment of migraine attacks in adults. It works by targeting specific serotonin receptors to relieve headache pain.

GNH USA supplies Imigran Ftab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution with regulatory approvals across major markets.

Imigran Ftab (sumatriptan) is indicated for acute migraine management, acting on the trigeminovascular pathway.

Migraine (with or without aura): rapid relief of headache pain and associated symptoms. Acute cluster headache: alleviation of severe unilateral head pain. Migraine (without aura): reduction of headache intensity and associated nausea.

Common Side Effects: - Chest tightness or pressure - Tingling or numbness in the face or extremities - Warmth or flushing sensation - Nausea or abdominal discomfort - Dizziness or light‑headedness - Fatigue or drowsiness

Serious or Rare Side Effects: - Coronary vasospasm or myocardial infarction - Severe hypertension or hypertensive crisis - Serotonin syndrome, especially with other serotonergic agents - Allergic reactions including rash, swelling, or anaphylaxis - Stroke or transient ischemic attack - Severe arrhythmias or cardiac arrest

Before using Imigran Ftab, consider the following precautions: - Cardiovascular disease: avoid use in patients with ischemic heart disease, angina, or prior myocardial infarction. - Uncontrolled hypertension: assess blood pressure and avoid if systolic >160 mmHg or diastolic >100 mmHg. - Serotonergic agents: monitor for signs of serotonin syndrome when combined with SSRIs, SNRIs, or MAO inhibitors. - Hemiplegic or basilar migraine: contraindicated due to increased vascular risk. - Use the lowest effective dose: follow prescriber guidance and do not exceed recommended frequency. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Imigran Ftab may interact with several medicines. Consider the following:

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension and serotonin syndrome. - Ergotamine or ergot derivatives: additive vasoconstriction may precipitate coronary events. - Other triptans: cumulative vasoconstrictive effect increases cardiovascular risk.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may enhance blood pressure‑lowering effects. - Oral contraceptives: possible increase in blood pressure; monitor regularly. - CYP3A4 inhibitors: may raise sumatriptan plasma levels, requiring dose adjustment.